- Home
- CVKD vs IMCC Comparison
CVKD vs IMCC Comparison
Compare CVKD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVKD | IMCC |
|---|---|---|
| Founded | 2022 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 10.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVKD | IMCC |
|---|---|---|
| Price | $11.06 | $1.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 43.2K | ★ 208.3K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $8.12 | $0.93 |
| 52 Week High | $22.90 | $7.12 |
Technical Indicators
Market Signals| Indicator | CVKD | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 59.41 |
| Support Level | $9.55 | $1.54 |
| Resistance Level | $12.00 | $1.84 |
| Average True Range (ATR) | 0.91 | 0.18 |
| MACD | 0.25 | 0.02 |
| Stochastic Oscillator | 74.23 | 69.33 |
Price Performance
Historical ComparisonAbout CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.